Atai Beckley N.V. (ATAI)

NASDAQ: ATAI · Real-Time Price · USD

4.320

-0.080 (-1.82%)

At close: Dec 5, 2025, 4:00 PM EST

4.250

-0.070 (-1.62%)

After-hours: Dec 5, 2025, 7:19 PM EST

Atai Beckley Employees

Atai Beckley had 54 employees as of December 31, 2024. The number of employees decreased by 29 or -34.94% compared to the previous year.

Employees

54

Change (1Y)

-29

Growth (1Y)

-34.94%

Revenue / Employee

$55,889

Profits / Employee

-$2,855,407

Market Cap

1.57B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	54	-29	-34.94%
Dec 31, 2023	83	-50	-37.59%
Dec 31, 2022	133	46	52.87%
Dec 31, 2021	87	52	148.57%
Dec 31, 2020	35	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

ATAI News

16 days ago - Enhanced Fortifies Executive Leadership Team & Board of Directors - PRNewsWire
24 days ago - Atai Beckley N.V. (ATAI) Discusses BPL-003 Phase IIb Open-Label Extension Study Results in Treatment Resistant Depression Transcript - Seeking Alpha
6 weeks ago - atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares - GlobeNewsWire
6 weeks ago - Atai Life Sciences And Beckley Psytech: Promising Emerging Leader In Psychedelics - Seeking Alpha
7 weeks ago - Why Atai Life Sciences Stock Was So Lively This Week - The Motley Fool
7 weeks ago - atai Life Sciences Announces Pricing of Public Offering of Common Shares - GlobeNewsWire
7 weeks ago - atai Life Sciences Announces Proposed Public Offering of Common Shares - GlobeNewsWire
7 weeks ago - atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression - GlobeNewsWire